Market Place
Sourcing Support
Amgen`s Rare Disease Drug Linked to Deaths with- liver injuries
16 May 2026 //
REUTERS
Merck, Amgen Intensify Efforts Against Top Killer Cholesterol
11 May 2026 //
BIOSPACE
Amgen to Present at BofA Global Healthcare Conference
08 May 2026 //
PR NEWSWIRE
Amgen, AbbVie say IRA Negotiations Impacted Q1 Sales
06 May 2026 //
ENDPOINTS
Amgen Adds $300M, Reaching $2B in U.S. Manufacturing
04 May 2026 //
PR NEWSWIRE
Amgen Launches Trial for Switchers from Rival Obesity Drugs
01 May 2026 //
ENDPOINTS
Amgen Updates Tavneos Label Amid FDA Withdrawal Push
01 May 2026 //
ENDPOINTS
Lilly Inks Deals; Regeneron Secures Historic Q1 Win
29 Apr 2026 //
BIOSPACE
Astrazeneca, Amgen To Pilot FDA`s Real-Time Trial Model
28 Apr 2026 //
FIRSTWORD PHARMA
FDA Proposes to withdraw Amgen`s drug for Rare Autoimmune Disease
27 Apr 2026 //
REUTERS
Amgen Announces Webcast of 2026 First Quarter Financial Results
25 Apr 2026 //
PR NEWSWIRE
David Reese To Retire From Amgen
23 Apr 2026 //
ENDPOINTS
Amgen Announces Retirement Of David Reese, EVP And CTO
22 Apr 2026 //
FIRSTWORD PHARMA
Merck`s PD-1/VEGF Data Shine in Stacked AACR `26 Lineup
17 Apr 2026 //
BIOSPACE
Boehringer, Amgen Scrap Immunology Assets, Citing Low Potential
14 Apr 2026 //
FIERCE BIOTECH
China Signs Off On Amgen`s Imdelltra
10 Apr 2026 //
FIERCE PHARMA
Amgen Awards Bradway With $24.7M Pay Package In `25
08 Apr 2026 //
FIERCE PHARMA
Amgen scores with trial of on-body injected version of Tepezza
06 Apr 2026 //
PRESS RELEASE
FDA warns of liver injury cases tied to Amgen`s Rare Disease Drug
31 Mar 2026 //
FDA
Viridian`s Tepezza Rival Scores Ph. 3 Win, But Investors Unsure
31 Mar 2026 //
FIERCE BIOTECH
Repatha Reduces First Major Cardiovascular Event Risk by 31%
29 Mar 2026 //
PR NEWSWIRE
GSK and Amgen to add medicines to TrumpRx
15 Mar 2026 //
REUTERS
The Next Cambridge? LA Sets Its Sights Higher
12 Mar 2026 //
BIOSPACE
Amgen Trims Horizon Subsidiary, F5 Shuts Down
11 Mar 2026 //
BIOSPACE
‘SNL’ Pokes Fun At Mysteries Of Amgen`s Otezla For Psoriasis
09 Mar 2026 //
FIERCE PHARMA
BMS` Celmod Drug Improves Myeloma PFS In Phase 3
09 Mar 2026 //
FIERCE BIOTECH
Amgen to Present at Leerink Partners Global Healthcare Conference
06 Mar 2026 //
PR NEWSWIRE
Amgen Announces 2026 Second Quarter Dividend
05 Mar 2026 //
PR NEWSWIRE
North Carolina Attracts Amgen, Roche For Next-Gen Obesity Drug
03 Mar 2026 //
BIOSPACE
Amgen to Present at 46th Annual TD Cowen Health Care Conference
24 Feb 2026 //
PR NEWSWIRE
EMA Seeks Input On Drafting Myasthenia Gravis Trial Guide
19 Feb 2026 //
RAPS
Matterworks Announces Update to Leadership Team
17 Feb 2026 //
PR NEWSWIRE
Amgen to Present at Citi`s 2026 Oncology Leadership Summit
13 Feb 2026 //
PR NEWSWIRE
EU Approves Amgen`s Uplizna for Generalized Myasthenia Gravis
13 Feb 2026 //
PR NEWSWIRE
OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia
06 Feb 2026 //
FIERCE PHARMA
Amgen Thumbs-Down on FDA’s ask, Tavneos Sales Continue
05 Feb 2026 //
FIERCE PHARMA
Amgen, Lilly Recommit to Puerto Rico Pharma Revival
03 Feb 2026 //
BIOSPACE
Amgen Reports Fourth Quarter and Full Year 2025 Financial Results
03 Feb 2026 //
PR NEWSWIRE
Amgen Terminates Autoimmune Partnership With Kyowa Kirin
02 Feb 2026 //
BIOSPACE
Amgen Exits $400M Autoimmune Pact After Running Vast Program
30 Jan 2026 //
FIERCE BIOTECH
Amgen Announces Q4 and FY 2025 Results Webcast
28 Jan 2026 //
PR NEWSWIRE
Biocom Unveils Keynote Panel With Abbvie, Amgen, Eli Lilly Heads
21 Jan 2026 //
BUSINESSWIRE
Nonprofit Health Services Organization Sues Fortune 500 Pharma
20 Jan 2026 //
BUSINESSWIRE
AbbVie, Amgen, Lilly Urge FDA to Update Post-Approval Rules
13 Jan 2026 //
BIOSPACE
Amgen says MariTide Helped Trial Patients Maintain Weight Loss
13 Jan 2026 //
REUTERS
Amgen to Present at 44th J.P. Morgan Healthcare Conference
07 Jan 2026 //
PR NEWSWIRE
DISCO Pharma Licenses Novel Cancer Surfaceome Targeted Therapies
07 Jan 2026 //
GLOBENEWSWIRE
Dark Blue Therapeutics Acquired By Amgen For Up To $840 Million
06 Jan 2026 //
PR NEWSWIRE
Abbvie Counters Amgen, Invests $100M In Trispecific Lung Cancer
05 Jan 2026 //
BIOSPACE
Amgen Collaborates with U.S. Government to Reduce Drug Costs
20 Dec 2025 //
PR NEWSWIRE
FDA Approves Uplizna for Generalized Myasthenia Gravis in Adults
11 Dec 2025 //
PR NEWSWIRE
Amgen Announces 2026 First Quarter Dividend
10 Dec 2025 //
PR NEWSWIRE
Inductive Bio Secures $21M To Enhance AI Drug Toxicity Models
08 Dec 2025 //
PR NEWSWIRE
Amgen signs on as 2026 World Cup host city supporter in LA
08 Dec 2025 //
FIERCE PHARMA
LASEC Names Amgen Official Biotech Partner For FIFA World Cup
05 Dec 2025 //
PR NEWSWIRE
Biocon Biologics Settles With Amgen For Denosumab Biosimilars
02 Dec 2025 //
EXPRESSPHARMA
Avantor Wins 2025 Edison Patent Award For Viral Inactivation Tech
25 Nov 2025 //
PR NEWSWIRE
Amgen to Present at 8 Th Evercore ISI Healthconx Conference
24 Nov 2025 //
PR NEWSWIRE
Amgen to Present at Citi`s 2025 Global Healthcare Conference
24 Nov 2025 //
PR NEWSWIRE
Survey Shows `cardiology deserts` at Heart of Amgen-Backed Drive
14 Nov 2025 //
FIERCE PHARMA
